Peer-influenced content. Sources you trust. No registration required. This is HCN.
Conexiant
The Aptima HPV assay uses messenger RNA detection to identify infections most likely to lead to cervical cancer.
Obstetrics & Gynecology February 11th 2026
Annals of Internal Medicine
Despite the scale of prostate-specific antigen (PSA) testing for prostate cancer screening, prediction models do not predict time-to-event end points or adjust for patient life expectancy.
Family Medicine/General Practice February 6th 2026
Oncology News Central (ONC)
“As an oncologist, when patients lost their hair, my response was, ‘Don’t worry. It will grow back.’ And it will grow back. But it really sucks as you’re waiting.” – Dr. Sue Hwang
Oncology, Medical February 2nd 2026
Cancer Therapy Advisor
The brothers falsely inflated OP-1250’s overall response rate from 9% to 17% and bumped up the expected phase II response rate from 18% to 36%.
Oncology Pharmacy February 2nd 2026
Medical Xpress
The findings provide significant conceptual advances into cancer neuroscience and establish therapeutic avenues that are distinct from present amyloid-lowering strategies, aiming at degrading the existing amyloid plaques.
Geriatrics February 2nd 2026
Epoch Health
“Patients and doctors [lack] enough research to inform medical guidelines and many patients are using these products without talking to their doctor about them.” —Senior White House official
Family Medicine/General Practice January 21st 2026